Skip to main content

Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R

Status: Coming Soon

Study details

View study details on clinicaltrials.gov.

Locations

  • San Francisco

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)

Hernan A Bazan, M.D., DFSVS, FACS
Hernan A Bazan, M.D., DFSVS, FACS
Principal investigator
View profile

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?